Loading company…
Tianjin vaccine developer and manufacturer focused on human vaccines, including influenza virus subunit vaccines.
ZYAK was established in 2001 and is based in Tianjin, China. It holds a High-Tech Enterprise Certificate and is engaged in research, development, production and sales of human vaccines, including influenza virus subunit vaccines. In July 2019 it raised CNY 250 million in Series A funding from China Capital Management, Efung Capital, Guoyu Investment, Huaige Capital, National Engineering Research Center of Veterinary Biologics, Shenzhen Kunding Venture Capital Investment and Shenzhen Qianhai Beizeng Capital Management.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in